Skip to main content
SpringerLink
Log in

ASO Author Reflections: An Opportunity to Provide Cost-Conscious Care for Patients Undergoing CRS-HIPEC

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

The substantial cost of care for patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy can be augmented by changes in practice patterns. This report discusses the recent publication of the authors’ group and their thoughts on cost-conscious cancer care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schwartz PB, Stahl CC, VandeWalle KA, et al. What drives high costs of cytoreductive surgery and HIPEC: patient, provider, or tumor? Ann Surg Oncol. 2020;27(13):4920–8. https://doi.org/10.1245/s10434-020-08583-7.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mogal HD, Levine EA, Fino NF, et al. Routine admission to intensive care unit after cytoreductive surgery and heated intraperitoneal chemotherapy: not always a requirement. Ann Surg Oncol. 2016;23:1486–95. https://doi.org/10.1245/s10434-015-4963-8.

    Article  PubMed  Google Scholar 

  3. Schwartz PB, Stahl CC, Vidri RJ, et al. Rethinking routine intensive care after cytoreductive surgery with heated intraperitoneal chemotherapy: the fiscal argument. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11967-6.

    Article  PubMed  Google Scholar 

  4. Lindrooth RC, Konetzka RT, Navathe AS, Zhu J, Chen W, Volpp K. The impact of profitability of hospital admissions on mortality. Health Serv Res. 2013;48(2 Pt 2):792–809. https://doi.org/10.1111/1475-6773.12026.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hoehn RS, Wima K, Vestal MA, et al. Effect of hospital safety-net burden on cost and outcomes after surgery. JAMA Surg. 2016;151:120–8. https://doi.org/10.1001/jamasurg.2015.3209.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award no. T32 ES007015. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health

Author information

Authors and Affiliations

  1. Department of Surgery, Division of Surgical Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA

    Patrick B. Schwartz MD & Daniel E. Abbott MD

Authors
  1. Patrick B. Schwartz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel E. Abbott MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick B. Schwartz MD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schwartz, P.B., Abbott, D.E. ASO Author Reflections: An Opportunity to Provide Cost-Conscious Care for Patients Undergoing CRS-HIPEC. Ann Surg Oncol 29, 6615–6616 (2022). https://doi.org/10.1245/s10434-022-12015-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12015-z

Search

Navigation